Eprazole sodium for injection is expected to complete the third phase of clinical research in June next year
-
Last Update: 2014-11-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Alprazole sodium for injection is a dosage form upgrade project of alprazole enteric coated tablets Tao Desheng, vice president of the company, once said that on the basis of effective promotion of the enteric coated tablets, the company will rapidly expand the new injection type According to the data, eprazole is a powerful ion pump inhibitor, mainly used for gastrointestinal diseases such as gastric ulcer and duodenal ulcer It is the exclusive variety of Lizhu group, and has entered the medical insurance catalogue of many provinces Insiders of the company disclosed that the sales of eprazole in the first half of this year was about 50 million, and the sales of this product is expected to achieve 50% growth this year.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
